joint pain on retatrutide Once-Weekly Reduces Weight and Knee in Patients With Obesity and Osteoarthritis Lilly's retatrutide shows solid weight

No, retatrutide and tirzepatide are not the same

Glycemic Safety Of particular importance given the glucagon receptor agonism component of retatrutide, there were no clinically significant increases in blood glucose or concerning hyperglycemic events despite glucagon's classical glucose-raising effects - confirming that the GLP-1 component successfully counteracts glucagon's impact on glucose homeostasis

Consult Pharm (2016) 31:68597

The ongoing development of novel agents, including the GLP-1/glucagon dual receptor agonist maxadutide and the exploration of triple receptor agonists, continues to expand treatment options